IL1B and diabetic kidney disease: For DKD, MIAT targeted and regulated TLR4 expression by acting as a ceRNA of miR-130a-3p, thereby promoting the release of TNF-α, IL-6, and IL-1β and subsequently initiated inflammatory reaction in immortalized podocytes (Zhang et al., 2020b).